3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet (ODT) Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3O9616
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Orally Disintegrating Tablet ODT Market Insights Forecast to 2028
BUY CHAPTERS

Global Orally Disintegrating Tablet (ODT) Market Research Report 2025

Code: QYRE-Auto-3O9616
Report
August 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Orally Disintegrating Tablet (ODT) Market Size

The global market for Orally Disintegrating Tablet (ODT) was valued at US$ 14900 million in the year 2024 and is projected to reach a revised size of US$ 18900 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Orally Disintegrating Tablet (ODT) Market

Orally Disintegrating Tablet (ODT) Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet (ODT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet (ODT).
The Orally Disintegrating Tablet (ODT) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablet (ODT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet (ODT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Orally Disintegrating Tablet (ODT) Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet (ODT) Market
Accounted market size in year US$ 14900 million
Forecasted market size in 2031 US$ 18900 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Segment by Application
  • CNS Diseases
  • Gastrointestinal Diseases
  • CVS Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Orally Disintegrating Tablet (ODT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Orally Disintegrating Tablet (ODT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Orally Disintegrating Tablet (ODT) Market growing?

Ans: The Orally Disintegrating Tablet (ODT) Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Orally Disintegrating Tablet (ODT) Market size in 2031?

Ans: The Orally Disintegrating Tablet (ODT) Market size in 2031 will be US$ 18900 million.

Who are the main players in the Orally Disintegrating Tablet (ODT) Market report?

Ans: The main players in the Orally Disintegrating Tablet (ODT) Market are Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer

What are the Application segmentation covered in the Orally Disintegrating Tablet (ODT) Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet (ODT) Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Others

What are the Type segmentation covered in the Orally Disintegrating Tablet (ODT) Market report?

Ans: The Types covered in the Orally Disintegrating Tablet (ODT) Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

1 Orally Disintegrating Tablet (ODT) Market Overview
1.1 Product Definition
1.2 Orally Disintegrating Tablet (ODT) by Type
1.2.1 Global Orally Disintegrating Tablet (ODT) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Others
1.3 Orally Disintegrating Tablet (ODT) by Application
1.3.1 Global Orally Disintegrating Tablet (ODT) Market Value by Application (2024 VS 2031)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Others
1.4 Global Orally Disintegrating Tablet (ODT) Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet (ODT) Revenue 2020-2031
1.4.2 Global Orally Disintegrating Tablet (ODT) Sales 2020-2031
1.4.3 Global Orally Disintegrating Tablet (ODT) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet (ODT) Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Orally Disintegrating Tablet (ODT) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Orally Disintegrating Tablet (ODT), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Product Type & Application
2.7 Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Date of Enter into This Industry
2.8 Global Orally Disintegrating Tablet (ODT) Market Competitive Situation and Trends
2.8.1 Global Orally Disintegrating Tablet (ODT) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Orally Disintegrating Tablet (ODT) Players Market Share by Revenue
2.8.3 Global Orally Disintegrating Tablet (ODT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orally Disintegrating Tablet (ODT) Market Scenario by Region
3.1 Global Orally Disintegrating Tablet (ODT) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Orally Disintegrating Tablet (ODT) Sales by Region: 2020-2031
3.2.1 Global Orally Disintegrating Tablet (ODT) Sales by Region: 2020-2025
3.2.2 Global Orally Disintegrating Tablet (ODT) Sales by Region: 2026-2031
3.3 Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2020-2031
3.3.1 Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2020-2025
3.3.2 Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2026-2031
3.4 North America Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet (ODT) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Orally Disintegrating Tablet (ODT) Sales by Country (2020-2031)
3.4.3 North America Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet (ODT) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Orally Disintegrating Tablet (ODT) Sales by Country (2020-2031)
3.5.3 Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet (ODT) Market Facts & Figures by Region
3.6.1 Asia Pacific Orally Disintegrating Tablet (ODT) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Orally Disintegrating Tablet (ODT) Sales by Region (2020-2031)
3.6.3 Asia Pacific Orally Disintegrating Tablet (ODT) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet (ODT) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Orally Disintegrating Tablet (ODT) Sales by Country (2020-2031)
3.7.3 Latin America Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet (ODT) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Orally Disintegrating Tablet (ODT) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orally Disintegrating Tablet (ODT) Sales by Type (2020-2031)
4.1.1 Global Orally Disintegrating Tablet (ODT) Sales by Type (2020-2025)
4.1.2 Global Orally Disintegrating Tablet (ODT) Sales by Type (2026-2031)
4.1.3 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2020-2031)
4.2 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2020-2031)
4.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2020-2025)
4.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2026-2031)
4.2.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2020-2031)
4.3 Global Orally Disintegrating Tablet (ODT) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet (ODT) Sales by Application (2020-2031)
5.1.1 Global Orally Disintegrating Tablet (ODT) Sales by Application (2020-2025)
5.1.2 Global Orally Disintegrating Tablet (ODT) Sales by Application (2026-2031)
5.1.3 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2020-2031)
5.2 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2020-2031)
5.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2020-2025)
5.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2026-2031)
5.2.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application (2020-2031)
5.3 Global Orally Disintegrating Tablet (ODT) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Orally Disintegrating Tablet (ODT) Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Orally Disintegrating Tablet (ODT) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Orally Disintegrating Tablet (ODT) Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Orally Disintegrating Tablet (ODT) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Company Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson and Johnson Orally Disintegrating Tablet (ODT) Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK Orally Disintegrating Tablet (ODT) Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka
6.7.1 Otsuka Company Information
6.7.2 Otsuka Description and Business Overview
6.7.3 Otsuka Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Orally Disintegrating Tablet (ODT) Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Company Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Orally Disintegrating Tablet (ODT) Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Conquer
6.11.1 Conquer Company Information
6.11.2 Conquer Description and Business Overview
6.11.3 Conquer Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Conquer Orally Disintegrating Tablet (ODT) Product Portfolio
6.11.5 Conquer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet (ODT) Industry Chain Analysis
7.2 Orally Disintegrating Tablet (ODT) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet (ODT) Production Mode & Process Analysis
7.4 Orally Disintegrating Tablet (ODT) Sales and Marketing
7.4.1 Orally Disintegrating Tablet (ODT) Sales Channels
7.4.2 Orally Disintegrating Tablet (ODT) Distributors
7.5 Orally Disintegrating Tablet (ODT) Customer Analysis
8 Orally Disintegrating Tablet (ODT) Market Dynamics
8.1 Orally Disintegrating Tablet (ODT) Industry Trends
8.2 Orally Disintegrating Tablet (ODT) Market Drivers
8.3 Orally Disintegrating Tablet (ODT) Market Challenges
8.4 Orally Disintegrating Tablet (ODT) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Orally Disintegrating Tablet (ODT) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Orally Disintegrating Tablet (ODT) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Orally Disintegrating Tablet (ODT) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Orally Disintegrating Tablet (ODT) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Orally Disintegrating Tablet (ODT) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Orally Disintegrating Tablet (ODT) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Orally Disintegrating Tablet (ODT) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Orally Disintegrating Tablet (ODT), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Product Type & Application
 Table 12. Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Orally Disintegrating Tablet (ODT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet (ODT) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Orally Disintegrating Tablet (ODT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Orally Disintegrating Tablet (ODT) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Region (2020-2025)
 Table 19. Global Orally Disintegrating Tablet (ODT) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Region (2026-2031)
 Table 21. Global Orally Disintegrating Tablet (ODT) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Region (2020-2025)
 Table 23. Global Orally Disintegrating Tablet (ODT) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Region (2026-2031)
 Table 25. North America Orally Disintegrating Tablet (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Orally Disintegrating Tablet (ODT) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Orally Disintegrating Tablet (ODT) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Orally Disintegrating Tablet (ODT) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Orally Disintegrating Tablet (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Orally Disintegrating Tablet (ODT) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Orally Disintegrating Tablet (ODT) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Orally Disintegrating Tablet (ODT) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Orally Disintegrating Tablet (ODT) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Orally Disintegrating Tablet (ODT) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Orally Disintegrating Tablet (ODT) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Orally Disintegrating Tablet (ODT) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Orally Disintegrating Tablet (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Orally Disintegrating Tablet (ODT) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Orally Disintegrating Tablet (ODT) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Orally Disintegrating Tablet (ODT) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Orally Disintegrating Tablet (ODT) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Orally Disintegrating Tablet (ODT) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Orally Disintegrating Tablet (ODT) Sales (K Units) by Type (2020-2025)
 Table 51. Global Orally Disintegrating Tablet (ODT) Sales (K Units) by Type (2026-2031)
 Table 52. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2020-2025)
 Table 53. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2026-2031)
 Table 54. Global Orally Disintegrating Tablet (ODT) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Orally Disintegrating Tablet (ODT) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2020-2025)
 Table 57. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2026-2031)
 Table 58. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Orally Disintegrating Tablet (ODT) Sales (K Units) by Application (2020-2025)
 Table 61. Global Orally Disintegrating Tablet (ODT) Sales (K Units) by Application (2026-2031)
 Table 62. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2020-2025)
 Table 63. Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2026-2031)
 Table 64. Global Orally Disintegrating Tablet (ODT) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Orally Disintegrating Tablet (ODT) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application (2020-2025)
 Table 67. Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application (2026-2031)
 Table 68. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Application (2026-2031)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Teva Orally Disintegrating Tablet (ODT) Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Orally Disintegrating Tablet (ODT) Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Mylan Orally Disintegrating Tablet (ODT) Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Orally Disintegrating Tablet (ODT) Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Johnson and Johnson Company Information
 Table 91. Johnson and Johnson Description and Business Overview
 Table 92. Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson and Johnson Orally Disintegrating Tablet (ODT) Product
 Table 94. Johnson and Johnson Recent Developments/Updates
 Table 95. GSK Company Information
 Table 96. GSK Description and Business Overview
 Table 97. GSK Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. GSK Orally Disintegrating Tablet (ODT) Product
 Table 99. GSK Recent Developments/Updates
 Table 100. Otsuka Company Information
 Table 101. Otsuka Description and Business Overview
 Table 102. Otsuka Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Otsuka Orally Disintegrating Tablet (ODT) Product
 Table 104. Otsuka Recent Developments/Updates
 Table 105. Eli Lilly and Company Company Information
 Table 106. Eli Lilly and Company Description and Business Overview
 Table 107. Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Eli Lilly and Company Orally Disintegrating Tablet (ODT) Product
 Table 109. Eli Lilly and Company Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. AstraZeneca Orally Disintegrating Tablet (ODT) Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Bristol-Myers Squibb Company Information
 Table 116. Bristol-Myers Squibb Description and Business Overview
 Table 117. Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Product
 Table 119. Bristol-Myers Squibb Recent Developments/Updates
 Table 120. Conquer Company Information
 Table 121. Conquer Description and Business Overview
 Table 122. Conquer Orally Disintegrating Tablet (ODT) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Conquer Orally Disintegrating Tablet (ODT) Product
 Table 124. Conquer Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Orally Disintegrating Tablet (ODT) Distributors List
 Table 128. Orally Disintegrating Tablet (ODT) Customers List
 Table 129. Orally Disintegrating Tablet (ODT) Market Trends
 Table 130. Orally Disintegrating Tablet (ODT) Market Drivers
 Table 131. Orally Disintegrating Tablet (ODT) Market Challenges
 Table 132. Orally Disintegrating Tablet (ODT) Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Orally Disintegrating Tablet (ODT)
 Figure 2. Global Orally Disintegrating Tablet (ODT) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Orally Disintegrating Tablet (ODT) Market Share by Type: 2024 & 2031
 Figure 4. Anti-Psychotics Drug Product Picture
 Figure 5. Anti-Epileptics Drug Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Orally Disintegrating Tablet (ODT) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Orally Disintegrating Tablet (ODT) Market Share by Application: 2024 & 2031
 Figure 9. CNS Diseases
 Figure 10. Gastrointestinal Diseases
 Figure 11. CVS Diseases
 Figure 12. Others
 Figure 13. Global Orally Disintegrating Tablet (ODT) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Orally Disintegrating Tablet (ODT) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Orally Disintegrating Tablet (ODT) Sales (2020-2031) & (K Units)
 Figure 16. Global Orally Disintegrating Tablet (ODT) Average Price (USD/Unit) & (2020-2031)
 Figure 17. Orally Disintegrating Tablet (ODT) Report Years Considered
 Figure 18. Orally Disintegrating Tablet (ODT) Sales Share by Manufacturers in 2024
 Figure 19. Global Orally Disintegrating Tablet (ODT) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Orally Disintegrating Tablet (ODT) Players: Market Share by Revenue in Orally Disintegrating Tablet (ODT) in 2024
 Figure 21. Orally Disintegrating Tablet (ODT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Orally Disintegrating Tablet (ODT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2020-2031)
 Figure 24. North America Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Orally Disintegrating Tablet (ODT) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Orally Disintegrating Tablet (ODT) Revenue Market Share by Region (2020-2031)
 Figure 36. China Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Orally Disintegrating Tablet (ODT) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Orally Disintegrating Tablet (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Orally Disintegrating Tablet (ODT) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Orally Disintegrating Tablet (ODT) by Type (2020-2031)
 Figure 58. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Orally Disintegrating Tablet (ODT) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Orally Disintegrating Tablet (ODT) by Application (2020-2031)
 Figure 61. Global Orally Disintegrating Tablet (ODT) Price (USD/Unit) by Application (2020-2031)
 Figure 62. Orally Disintegrating Tablet (ODT) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS